MedTrace Logo

Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism

NCT02064543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2019-09-18

No results posted yet for this study

Summary

The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who are able to provide informed consent will participate in the assessments.

Outcome variables include selected gait and balance parameters such as cadence, gait-cycle, stride-length, stride-velocity, turning duration, turning steps, postural sway and anticipatory postural control. These parameters will be measured by the portable inertial sensors developed by APDM® and the Zeno/GaitRite.

Conditions

  • Parkinsonism

Interventions

OTHER

GAITRite

mobility test assessing gait parameters

OTHER

ADPM

mobility test assessing gait parameters

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Pravin Khemani, M.D. · UT Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064543 on ClinicalTrials.gov